DERIVATIVE LIABILITIES FOR AUTHORIZED SHARE DEFICIENCIES - Derivative Liability Associated with Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
May 26, 2021 |
Feb. 17, 2021 |
May 26, 2022 |
---|---|---|---|
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items] | |||
Number of shares | 733 | 780 | |
Weighted average fair value per share | $ 2.45 | $ 4.60 | |
Fair value of derivative liability | $ 1,796 | $ 3,591 | $ 1,800 |
Stock Options | |||
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items] | |||
Number of shares | 212 | 253 | |
Weighted average fair value per share | $ 4.42 | $ 6.46 | |
Fair value of derivative liability | $ 935 | $ 1,638 | |
Warrants | |||
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items] | |||
Number of shares | 521 | 527 | |
Weighted average fair value per share | $ 1.65 | $ 3.71 | |
Fair value of derivative liability | $ 861 | $ 1,953 |
X | ||||||||||
- Definition The number of common shares below the required amount to be authorized causing a deficiency. No definition available.
|
X | ||||||||||
- Definition The weighted average fair value per share of deficient shares. No definition available.
|
X | ||||||||||
- Definition Fair value of the deficient common shares below the required amount to be authorized. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|